Amlno5-(5-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation

Details for Australian Patent Application No. 2006266129 (hide)

Owner Wyeth

Inventors Andrae, Patrick Michael; Malamas, Michael Sotirios; Fobare, William Floyd; Quagliato, Dominick Anthony; Erdei, James Joseph; Gunawan, Iwan Suwandi; Yan, Yinfa; Zhou, Ping; Solvibile, William Ronald

Agent Davies Collison Cave

Pub. Number AU-A-2006266129

PCT Pub. Number WO2007/005366

Priority 60/695,353 30.06.05 US

Filing date 26 June 2006

Wipo publication date 11 January 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4178 (2006.01)

A61K 31/4439 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/005366 Priority application(s): WO2007/005366

17 April 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Wyeth, Application No. 2006266129, Under INID (54), correct the title to Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation.

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006266137-Protection of solid acid catalysts from damage by volatile species

2006266125-Compositions for treating or preventing obesity and insulin resistance disorders